Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

You say something has to give and that obviously they won't dilute, so that leaves two options to address the dwindling cash: a licensing deal or to sell the company. You say there is no evidence of a sale, but there is also no evidence they won't dilute. We hope they won't dilute just like some hope there is a sale, but you seem to make it out to be a matter of fact they won't dilute. How is that different than thinking a sale is coming. We don't know if a sale is coming just as we don't know that they won't dilute.